Animal Antimicrobials and Antibiotics Market by Products, Animals & Mode of
dZ ^ v]u o vš]u] Œ} ] o• v vš] ]}š] • D Œl š by Products (Tetracyclines, Penicillins,
Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery
(Premixes, Oral Powders and Solutions, Injections) - 'o} o &}Œ •š• š} îìíô_U v oÇÌ •
and studies the major market drivers, restraints, and opportunities in North America,
Europe, Asia, and the Rest of the World (RoW).
Browse 128 market data tables, 40 figures spread through 274 pages and in-depth TOC
Early buyers will receive 10% customization in this report.
The animal antimicrobials and antibiotics market was valued at $3,340.8 million in 2013
and is expected to grow at a modest CAGR of 4.4% from 2013 to 2018.
In this report, the global animal antimicrobials and antibiotics market is segmented based
on products, animals, mode of delivery, and geography.
Based on the different types of products, the animal antimicrobials and antibiotics market
is classified into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides,
cephalosporin and others. Based on animals type, the global animal antimicrobial and
antibiotics market is segmented into companion animals ( dogs, cats, and horses) and
food-producing animals (poultry, pigs, cattle, sheep and goats), and other animals (fishes,
rabbits and other animals).
Based on the various modes of delivery, the global market is divided into premix, oral
powder and solutions, injections, intramammary preparations and others.
Get PDF Brochure :
Tetracyclines dominated the animal antimicrobials and antibiotics product segment in
2013, accounting for around 60% of the market revenue.
By animal types, the antimicrobials and antibiotics market for pigs dominated the global
market with a share of nearly 25% in 2013. By mode of delivery, premixes were the major
revenue contributor in 2013, with an estimated share of nearly 49% n 2013.
The rising demand for animal protein products in the emerging countries and the
increasing trend for companion animal ownership are some of the factors driving the
growth of this market.
Request for Customization of Report:
North America accounted for the largest share of the global animal antimicrobial and
antibiotics market in 2013, followed by Europe, Asia, and the Rest of the World. Developed
geographies like North America and Europe are likely to grow at lower CAGRs as compared
to the Asian and RoW market. The growth in the Asian and RoW market is attributed to
the rise in demand for animal protein products, along with an increase in the trend of
companion animal ownership in the region.
Some of the major players in the animal antimicrobials and antibiotics market include
Zoetis Inc. (U.S.), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Merial (U.S.),
Bayer Animal Health (Germany), Virbac Animal Health (U.S.), and CEVA Santé Animale
(U.S.)., among others.
MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals, including
advanced materials, automotive and transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy and power, food and beverages,
industrial automation, medical devices, pharmaceuticals, semiconductor and electronics,
and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business
insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252